Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Aggrastat
Also marketed in the EU under the name(s): Agrastat
Active substance: Irbesartan
Indication: prevention of early myocardial infarction in patients presenting with unstable angina or non-Q-wave myocardial infarction with the last episode of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/06/1999 Referral EMEA/H/A/265 (1999)1656 of 18/06/1999